EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
01 1EUROAPI Hungary Ltd.
02 1Granules India Limited
03 1Teva API India Private Ltd
04 1Amoli Organics (A Division of Umedica Laboratories Pvt.Ltd.)
05 2Aurobindo Pharma Limited
06 1CTX Lifesciences Pvt. Ltd.
07 1Cadila Pharmaceuticals Limited
08 1Catalent Micron Technologies, Inc.
09 2Chieron Active Ingredients Private Limited
10 1Divi's Laboratories Limited
11 2Glenmark Life Sciences Limited
12 1Hetero Labs Limited
13 1Jubilant Pharmova Limited
14 1MSN Laboratories Private Limited
15 1MYLAN LABORATORIES LIMITED
16 1Matrix Pharmacorp Private Limited
17 1Micro Labs Limited
18 1Vasudah Pharma Chem Limited
19 1Vasudha Pharma Chem Limited
20 1Viyash Life Sciences Private Limited
21 1YiChang HEC ChangJiang Pharmaceutical Co.,Ltd.
22 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
23 1Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
24 1Zydus Lifesciences Limited
01 4OLMESARTAN MEDOXOMIL
02 22Olmesartan Medoxomil
03 1Olmesartan Medoxomil (Process-II)
01 3China
02 1France
03 16India
04 1Israel
05 2U.S.A
06 4Blank
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
NDC Package Code : 82231-116
Start Marketing Date : 2023-10-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-018
Start Marketing Date : 2025-11-10
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
NDC Package Code : 15894-0019
Start Marketing Date : 2015-12-14
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49587-110
Start Marketing Date : 2016-06-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42571-279
Start Marketing Date : 2013-09-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0011
Start Marketing Date : 2010-03-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12666-0021
Start Marketing Date : 2012-03-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52038-006
Start Marketing Date : 2019-10-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 42419-034
Start Marketing Date : 2024-10-24
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 52038-003
Start Marketing Date : 2010-06-16
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
88
PharmaCompass offers a list of Olmesartan Medoxomil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Olmesartan Medoxomil manufacturer or Olmesartan Medoxomil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Olmesartan Medoxomil manufacturer or Olmesartan Medoxomil supplier.
PharmaCompass also assists you with knowing the Olmesartan Medoxomil API Price utilized in the formulation of products. Olmesartan Medoxomil API Price is not always fixed or binding as the Olmesartan Medoxomil Price is obtained through a variety of data sources. The Olmesartan Medoxomil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Olmesartan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olmesartan, including repackagers and relabelers. The FDA regulates Olmesartan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olmesartan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Olmesartan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Olmesartan supplier is an individual or a company that provides Olmesartan active pharmaceutical ingredient (API) or Olmesartan finished formulations upon request. The Olmesartan suppliers may include Olmesartan API manufacturers, exporters, distributors and traders.
click here to find a list of Olmesartan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Olmesartan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Olmesartan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Olmesartan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Olmesartan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Olmesartan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Olmesartan suppliers with NDC on PharmaCompass.
We have 20 companies offering Olmesartan
Get in contact with the supplier of your choice:
